Tyler R McCaw (Tyler McCaw)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 9

Top Venues

Journal of surgical oncology

Cancer immunology, immunotherapy : CII

Cancers

Cancer medicine

Biogen Idec Inc

North Carolina State University (BSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Biogen Idec Inc

United States

Engineer I :: Technical Development

Education History

North Carolina State University

United States

BSC :: Engineering; Molecular and Structural Biochemistry

Publications

Kyle D Klingbeil, Blake R Wilde, Danielle S Graham, Serena Lofftus, Tyler R McCaw, Nedas Matulionis, Sarah M Dry, Joseph G Crompton, Fritz Christian Eilber, Thomas Glen Graeber, David B Shackelford, Heather R Christofk, Brian E Kadera
Targeting Asparagine Metabolism in Well-Differentiated/Dedifferentiated Liposarcoma. Cancers 16 (17) (2024)
Michael S Shehata, Serena Y Lofftus, Joon Y Park, Arun S Singh, Noah C Federman, Fritz C Eilber, Joseph G Crompton, Tyler R McCaw
Sarcoma in patients with Lynch syndrome and response to immunotherapy. Journal of surgical oncology 129 (4) (2023)
Michael S Shehata, Serena Y Lofftus, Joon Y Park, Arun S Singh, Noah C Federman, Fritz C Eilber, Joseph G Crompton, Tyler R McCaw
Sarcoma in patients with Lynch syndrome and response to immunotherapy. Journal of surgical oncology (2023)
Michael S Shehata, Serena Y Lofftus, Joon Y Park, Arun S Singh, Noah C Federman, Fritz C Eilber, Joseph G Crompton, Tyler R McCaw
Sarcoma in patients with Lynch syndrome and response to immunotherapy. Journal of surgical oncology 129 (4) (2023)
Tyler R McCaw, Evelyn Inga, Herbert Chen, Renata Jaskula-Sztul, Vikas Dudeja, James A Bibb, Bin Ren, John Bart Rose
Gamma Secretase Inhibitors in Cancer: A Current Perspective on Clinical Performance. The oncologist 26 (4) (2021)
Meagan M Jenkins, Tyler R McCaw, Paul A Goepfert
Mechanistic inferences from clinical reports of SARS-CoV-2. Infectious diseases (London, England) 52 (8) (2020)
Tyler R McCaw, Nidhi Goel, Dewey J Brooke, Ashwini A Katre, Angelina I Londoño, Haller J Smith, Troy D Randall, Rebecca C Arend
Class I histone deacetylase inhibition promotes CD8 T cell activation in ovarian cancer. Cancer medicine 10 (2) (2020)
Tyler R McCaw, Mei Li, Dmytro Starenki, Mingyong Liu, Sara J Cooper, Rebecca C Arend, Andres Forero, Donald J Buchsbaum, Troy D Randall
Histone deacetylase inhibition promotes intratumoral CD8+ T-cell responses, sensitizing murine breast tumors to anti-PD1. Cancer immunology, immunotherapy : CII 68 (12) (2019)
Tyler R McCaw, Mei Li, Dmytro Starenki, Sara J Cooper, Mingyong Liu, Selene Meza-Perez, Rebecca C Arend, Donald J Buchsbaum, Andres Forero, Troy D Randall
The expression of MHC class II molecules on murine breast tumors delays T-cell exhaustion, expands the T-cell repertoire, and slows tumor growth. Cancer immunology, immunotherapy : CII 68 (2) (2018)

Tyler R McCaw.css-eqlu8i{font-size:small;padding-left:4px;} (Tyler McCaw)

Publication Activity (10 Years)

Top Topics

Top Venues

Tyler R McCaw (Tyler McCaw)